International consensus statement on major depressive disorder.
about
Clinical practice guidelines in psychiatry: more confusion than clarity? A critical review and recommendation of a unified guidelinePredicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesRediscovering trazodone for the treatment of major depressive disorderMultimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy.Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review studyDepressed patients' preferences for type of psychotherapy: a preliminary studyEfficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial.A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in JapanDosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box WarningSystematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.Major depression in primary care: making the diagnosis.Efficacy of adjunctive aripiprazole in major depressive disorder: a pooled response quartile analysis and the predictive value of week 2 early response.Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.Managing depression in primary care.Factors impacting the efficacy of venlafaxine extended release 75-225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan.Different indications, warnings and precautions, and contraindications for the same drug-an international comparison of prescribing information for commonly used psychiatric drugs
P2860
Q26830411-74C94529-3F13-4347-A71F-2F64C18C3AE9Q31049668-5A3C9F38-DD7B-4AF1-BB2E-3F1D49108D88Q34237681-B19A272E-29A7-4E1B-BE77-41396092156DQ34314280-0004577F-B9EB-43D1-95AE-F0D0BC03FE7AQ34559591-08BDBA8A-4D32-4F75-A625-F8EE5C991773Q34629315-456EFD70-77B4-40CB-84FB-5397F8ED0500Q35666205-413A089A-45E5-4173-9001-F773B4ADDB95Q36140106-B6A137E3-17BB-4967-BFCF-63E07810241FQ36332534-7ED62199-0F93-4843-8EF9-A872B0675ECFQ36341769-59A7587B-2E6E-431B-A0D0-F76DD0BF3955Q37275848-F99AB90F-7234-4E4F-A5F7-887CEB67DD0AQ37635714-4C6D1F69-1E13-432B-8906-C72A09B1515CQ37672555-8DDC850F-B555-4CE7-92E0-878A1543CFD0Q38462018-DE655B4F-CE09-4743-A4D8-512B42D632CDQ48031940-9839CD5C-282F-4C30-92FB-2C38D8BA0DAEQ52313971-75AD9FD8-4178-4CF8-A9A0-E3412699BCA0Q54974160-C061454E-9CA2-4186-972F-540D1F26D87AQ57779934-3D638E5D-5853-4345-935B-0C0EB4257B8A
P2860
International consensus statement on major depressive disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
International consensus statement on major depressive disorder.
@en
International consensus statement on major depressive disorder.
@nl
type
label
International consensus statement on major depressive disorder.
@en
International consensus statement on major depressive disorder.
@nl
prefLabel
International consensus statement on major depressive disorder.
@en
International consensus statement on major depressive disorder.
@nl
P2093
P1476
International consensus statement on major depressive disorder.
@en
P2093
Alan J Gelenberg
George I Papakostas
Jonathan R T Davidson
Kaoru Sakamoto
Mingyuan Zhang
Oğuz Karamustafalioğlu
Shigenobu Kanba
Takeshi Terao
Teruhiko Higuchi
P356
10.4088/JCP.9058SE1C.08GRY
P478
71 Suppl E1
P50
P577
2010-01-01T00:00:00Z